Rewind Therapeutics

Rewind Therapeutics is a company developing first-class treatments for demyelination-related diseases. Rewind Therapeutics is creating cutting-edge therapies designed to restart the myelination process in patients suffering from severely debilitating conditions such as multiple sclerosis, optic neuritis, or nerve damage. Repairing or reinstalling this sheath (i.e., remyelination) is a key factor in halting or reversing disease progression and potentially even curing these diseases. Rewind’s team possesses extensive R&D expertise and has established robust patent rights for the development of novel myelination therapies.